Haleon, Richmond

Advil-maker Haleon investing $54.2 million in its Richmond plant
The maker of Advil, Tums and Sensodyne toothpaste is investing $54.2 million to upgrade its global research and development facility in Richmond. Why it matters: The upgrades could lead to more local jobs and help establish the region as a "pharma corridor,
Drugmaker Haleon will spend $54 million upgrading Richmond lab
Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh Toothpaste.
What Haleon's $54.2 million investment means for Richmond
Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced plans to upgrade its Richmond research and development facility.
Haleon to invest $54 million in US R&D centre to boost product innovation
Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.
Richmond rises as pharma hub: Haleon invests $54 million and launches paid internship program
Richmond is cementing its status as a hub for pharmaceutical innovation, with Gov. Glenn Youngkin dubbing the region a “Pharma Corridor” during Monday’s announcement of major investments and opportunities at Haleon,
$54M in upgrades planned at Haleon R&D facility in Northside
The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such brands as Sensodyne toothpaste, Centrum multivitamins and Flonase nasal spray.
Haleon Will Invest $54.2M In A Richmond, Virginia, R&D Facility
The consumer health company site will launch an internship program with the state government and Virginia Commonwealth University
UK pharmaceutical company Haleon expanding R&D facility in Richmond
The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.
Pharma company to invest $54.2M in Richmond R&D facility
Listen to this article Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership with state government and Virginia Commonwealth University,
Haleon to invest $54 mln in US R&D centre to boost product innovation
Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.
London South East1y
Haleon Plc Ord Gbp0.01
The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.
Hosted on MSN2d
Richmond consumer health facility announces $54 million dollar upgrade
Haleon, a global consumer health company behind products like Advil, Aquafresh and Polident, announced a $54.2 million ...